CRVS
Corvus Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $998.52M
- Employees
- 37
- Latest publication
- 2026-09-29
About Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The company's lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1b/2 clinical trial for the treatment of peripheral T cell lymphoma, atopic dermatitis, hidradenitis suppurativa, autoimmune lymphoproliferative syndrome, and solid tumors monotherapy, and asthma, diseases. It also developing ciforadenant (CPI-444), an oral small molecule antagonist of the A2A receptor that is in Phase 2 clinical trial for the treatment of first line renal cell cancer; and mupadolimab (CPI-006), a humanized monoclonal antibody, which is in Phase 1 clinical trial for the treatment of non-small cell lung cancer. It has a license agreement with Monash University to research, develop, and commercialize certain antibodies directed to CXCR2 for the treatment of human diseases; and Vernalis (R&D) Limited to develop, manufacture, and commercialize products containing certain adenosine receptor antagonists, including ciforadenant, as well as license agreement with Scripps for the development and commercialization of mupadolimab. Corvus Pharmaceuticals, Inc. was incorporated in 2014 and is based in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 88,000USD | 0USD | 0USD |
| Cost Of Revenue | 29,000USD | 26,000USD | — | 29,000USD | 22,000USD | 44,000USD | 20,000USD | 21,000USD |
| Gross Profit | -29,000USD | -26,000USD | — | -29,000USD | -22,000USD | 44,000USD | -20,000USD | -21,000USD |
| Research Development | 11,175,000USD | 9,939,000USD | 8,454,000USD | 7,873,000USD | 7,453,000USD | 5,974,000USD | 5,222,000USD | 4,114,000USD |
| Selling General Administrative | 3,702,000USD | 2,278,000USD | 2,118,000USD | 2,387,000USD | 2,469,000USD | 2,131,000USD | 2,033,000USD | 1,821,000USD |
| Total Operating Expenses | 14,877,000USD | 12,191,000USD | 10,572,000USD | 10,260,000USD | 9,922,000USD | 8,105,000USD | 7,255,000USD | 5,935,000USD |
| Operating Income | -14,877,000USD | -12,217,000USD | -10,572,000USD | -10,260,000USD | -9,922,000USD | -8,105,000USD | -7,255,000USD | -5,935,000USD |
| Interest Income | 1,784,000USD | 603,000USD | 738,000USD | 639,000USD | 525,000USD | 508,000USD | 566,000USD | 434,000USD |
| Interest Expense | 1,784,000USD | 2,505,000USD | 738,000USD | 639,000USD | 525,000USD | — | 566,000USD | 434,000USD |
| Net Interest Income | 1,784,000USD | 603,000USD | 738,000USD | 639,000USD | 525,000USD | 508,000USD | 566,000USD | 434,000USD |
| Income Before Tax | -13,692,000USD | -12,321,000USD | -10,157,000USD | -7,998,000USD | 15,193,000USD | -12,113,000USD | -40,217,000USD | -4,262,000USD |
| Net Income | -13,692,000USD | -12,321,000USD | -10,157,000USD | -7,998,000USD | 15,193,000USD | -12,113,000USD | -40,217,000USD | -4,262,000USD |
| Net Income From Continuing Ops | -13,692,000USD | -12,321,000USD | -10,157,000USD | -7,998,000USD | 15,193,000USD | -12,113,000USD | -40,217,000USD | -4,262,000USD |
| Ebit | -11,908,000USD | -12,321,000USD | -10,157,000USD | -7,998,000USD | 15,193,000USD | -12,113,000USD | -40,217,000USD | -4,262,000USD |
| Ebitda | -11,879,000USD | -12,295,000USD | -10,129,000USD | -7,969,000USD | 15,215,000USD | -12,093,000USD | -40,196,000USD | -4,241,000USD |
| Depreciation And Amortization | 29,000USD | 26,000USD | 28,000USD | 29,000USD | 22,000USD | 20,000USD | 21,000USD | 21,000USD |
| Reconciled Depreciation | 29,000USD | 26,000USD | 28,000USD | 29,000USD | 22,000USD | 20,000USD | 21,000USD | 21,000USD |
| Total Other Income Expense Net | 1,185,000USD | -104,000USD | 415,000USD | 2,262,000USD | 25,115,000USD | -4,008,000USD | -32,962,000USD | 1,673,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 21,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 105,000USD | 85,000USD | 151,000USD | 632,000USD | 743,000USD | 842,000USD | 594,000USD | 148,000USD |
| Gross Profit | -105,000USD | -85,000USD | -151,000USD | -632,000USD | -743,000USD | -842,000USD | -594,000USD | -148,000USD |
| Research Development | 33,719,000USD | 19,385,000USD | 16,526,000USD | 31,830,000USD | 37,975,000USD | 46,305,000USD | 29,356,000USD | 11,352,000USD |
| Selling General Administrative | 9,252,000USD | 8,163,000USD | 6,881,000USD | 11,930,000USD | 10,879,000USD | 10,219,000USD | 7,620,000USD | 2,418,000USD |
| Total Operating Expenses | 42,866,000USD | 27,548,000USD | 23,407,000USD | 43,760,000USD | 48,854,000USD | 56,524,000USD | 36,976,000USD | 13,770,000USD |
| Operating Income | -42,971,000USD | -27,548,000USD | -23,407,000USD | -43,760,000USD | -48,854,000USD | -56,524,000USD | -36,976,000USD | -13,770,000USD |
| Interest Income | 2,505,000USD | 1,824,000USD | 1,584,000USD | 540,000USD | 2,182,000USD | 861,000USD | 601,000USD | 17,565,000USD |
| Interest Expense | 2,505,000USD | 1,824,000USD | 1,584,000USD | 540,000USD | 2,182,000USD | 0USD | 601,000USD | 0USD |
| Net Interest Income | 2,505,000USD | 1,824,000USD | 1,522,000USD | 540,000USD | 2,182,000USD | 861,000USD | 601,000USD | — |
| Income Before Tax | -15,283,000USD | -62,293,000USD | -27,029,000USD | -5,995,000USD | -46,672,000USD | -55,663,000USD | -36,375,000USD | -31,335,000USD |
| Net Income | -15,283,000USD | -62,293,000USD | -27,029,000USD | -4,823,000USD | -43,747,000USD | -55,663,000USD | -36,375,000USD | -31,335,000USD |
| Net Income From Continuing Ops | -15,283,000USD | -62,293,000USD | -30,192,000USD | -5,995,000USD | -46,672,000USD | -55,663,000USD | -36,375,000USD | -31,335,000USD |
| Ebit | -15,283,000USD | -62,293,000USD | -27,029,000USD | -43,760,000USD | -48,854,000USD | -56,524,000USD | -36,976,000USD | -31,335,000USD |
| Ebitda | -15,178,000USD | -62,208,000USD | -26,878,000USD | -43,128,000USD | -48,111,000USD | -55,682,000USD | -36,382,000USD | -31,187,000USD |
| Depreciation And Amortization | 105,000USD | 85,000USD | 151,000USD | 632,000USD | 743,000USD | 842,000USD | 594,000USD | 148,000USD |
| Reconciled Depreciation | 105,000USD | 85,000USD | 217,000USD | 632,000USD | 743,000USD | 842,000USD | — | — |
| Total Other Income Expense Net | 27,688,000USD | -34,745,000USD | -3,622,000USD | 37,765,000USD | 2,182,000USD | 861,000USD | 601,000USD | -17,565,000USD |
| Selling And Marketing Expenses | — | — | 151,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | — | -1,172,000USD | -2,925,000USD | -842,000USD | -594,000USD | -35,000USD |
| Non Operating Income Net Other | — | — | — | 37,999,000USD | 2,182,000USD | 861,000USD | 601,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | -5,995,000USD | -46,672,000USD | -55,663,000USD | -36,375,000USD | -31,335,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 253,195,000USD | 71,119,000USD | 80,474,000USD | 89,461,000USD | 59,438,000USD | 68,907,000USD | 58,815,000USD | 64,561,000USD |
| Other Current Assets | 2,034,000USD | 1,090,000USD | 909,000USD | 1,114,000USD | 1,052,000USD | 2,227,000USD | 1,049,000USD | 890,000USD |
| Total Liab | 12,516,000USD | 9,914,000USD | 8,706,000USD | 9,233,000USD | 10,113,000USD | 36,339,000USD | 46,406,000USD | 13,335,000USD |
| Total Stockholder Equity | 240,679,000USD | 61,205,000USD | 71,768,000USD | 80,228,000USD | 49,325,000USD | 32,568,000USD | 12,409,000USD | 51,226,000USD |
| Other Current Liab | 6,985,000USD | 6,486,000USD | 5,721,000USD | 5,013,000USD | 7,652,000USD | 32,635,000USD | 44,179,000USD | 11,422,000USD |
| Common Stock | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 6,000USD | 6,000USD |
| Capital Stock | 8,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 7,000USD | 6,000USD | 6,000USD |
| Retained Earnings | -425,985,000USD | -412,293,000USD | -399,972,000USD | -389,815,000USD | -381,817,000USD | -397,010,000USD | -384,897,000USD | -344,680,000USD |
| Cash | 40,102,000USD | 4,576,000USD | 2,867,000USD | 14,691,000USD | 4,999,000USD | 8,740,000USD | 4,680,000USD | 14,841,000USD |
| Cash And Short Term Investments | 236,714,000USD | 56,750,000USD | 65,689,000USD | 74,407,000USD | 44,212,000USD | 51,964,000USD | 41,651,000USD | 47,246,000USD |
| Total Current Assets | 239,946,000USD | 58,214,000USD | 66,944,000USD | 75,780,000USD | 45,491,000USD | 54,407,000USD | 42,921,000USD | 48,258,000USD |
| Total Current Liabilities | 12,110,000USD | 9,380,000USD | 8,074,000USD | 8,505,000USD | 9,279,000USD | 35,402,000USD | 46,406,000USD | 13,335,000USD |
| Net Debt | -39,268,000USD | -3,639,000USD | -1,856,000USD | -13,608,000USD | -3,846,000USD | -7,618,000USD | -4,326,000USD | -14,141,000USD |
| Short Term Debt | 428,000USD | 403,000USD | 379,000USD | 355,000USD | 319,000USD | 185,000USD | 354,000USD | 700,000USD |
| Short Long Term Debt Total | 834,000USD | 937,000USD | 1,011,000USD | 1,083,000USD | 1,153,000USD | 1,122,000USD | 354,000USD | 700,000USD |
| Long Term Investments | 10,496,000USD | 10,991,000USD | 11,530,000USD | 11,794,000USD | 12,058,000USD | 12,540,000USD | 15,187,000USD | 15,404,000USD |
| Short Term Investments | 196,612,000USD | 52,174,000USD | 62,822,000USD | 59,716,000USD | 39,213,000USD | 43,224,000USD | 36,971,000USD | 32,405,000USD |
| Net Receivables | 1,198,000USD | 374,000USD | 346,000USD | 259,000USD | 227,000USD | 216,000USD | 221,000USD | 122,000USD |
| Accounts Payable | 4,697,000USD | 2,491,000USD | 1,974,000USD | 3,137,000USD | 1,308,000USD | 2,582,000USD | 1,873,000USD | 1,213,000USD |
| Property Plant Equipment Net | 1,033,000USD | 1,059,000USD | 1,148,000USD | 1,261,000USD | 1,260,000USD | 1,328,000USD | 455,000USD | 770,000USD |
| Property Plant Equipment Gross | 3,710,000USD | 3,708,000USD | 3,770,000USD | 3,855,000USD | 3,824,000USD | 5,954,000USD | 5,076,000USD | 5,370,000USD |
| Accumulated Other Comprehensive Income | -1,126,000USD | -896,000USD | -1,060,000USD | -1,148,000USD | -1,254,000USD | -1,288,000USD | -738,000USD | -1,355,000USD |
| Common Stock Shares Outstanding | 89,996,728shares | 79,742,685shares | 82,836,369shares | 77,774,344shares | 75,152,514shares | 68,347,016shares | 66,701,086shares | 59,710,265shares |
| Non Current Assets Total | 13,249,000USD | 12,905,000USD | 13,530,000USD | 13,681,000USD | 13,947,000USD | 14,500,000USD | 15,894,000USD | 16,303,000USD |
| Non Current Liabilities Total | 406,000USD | 533,999USD | 632,000USD | 728,000USD | 834,000USD | 937,000USD | 0USD | 0USD |
| Non Currrent Assets Other | 1,720,000USD | 855,000USD | 852,000USD | 626,000USD | 629,000USD | 632,000USD | 252,000USD | 129,000USD |
| Net Working Capital | 227,836,000USD | 48,834,000USD | 58,870,000USD | 67,275,000USD | 36,212,000USD | 19,005,000USD | -3,485,000USD | 34,923,000USD |
| Unclassified Equity | 667,774,000USD | 474,380,000USD | 472,786,000USD | 471,177,000USD | 432,382,000USD | 430,852,000USD | 398,032,000USD | 397,249,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 71,119,000USD | 68,907,000USD | 45,553,000USD | 68,240,000USD | 109,455,000USD | 85,529,000USD | 83,646,000USD | 118,232,000USD |
| Other Current Assets | 1,090,000USD | 2,227,000USD | 744,000USD | 728,000USD | 1,322,000USD | 1,077,000USD | 1,033,000USD | 655,000USD |
| Total Liab | 9,914,000USD | 36,339,000USD | 6,869,000USD | 12,125,000USD | 12,293,000USD | 13,381,000USD | 12,535,000USD | 7,896,000USD |
| Total Stockholder Equity | 61,205,000USD | 32,568,000USD | 38,684,000USD | 56,115,000USD | 97,162,000USD | 72,148,000USD | 71,111,000USD | 110,336,000USD |
| Other Current Liab | 6,486,000USD | 32,635,000USD | 3,970,000USD | 7,548,000USD | 7,081,000USD | 7,604,000USD | 6,899,000USD | 5,029,000USD |
| Common Stock | 7,000USD | 7,000USD | 5,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD |
| Capital Stock | 7,000USD | 7,000USD | 5,000USD | 5,000USD | 5,000USD | 3,000USD | 3,000USD | 3,000USD |
| Retained Earnings | -412,293,000USD | -397,010,000USD | -334,717,000USD | -307,688,000USD | -266,381,000USD | -223,140,000USD | -217,145,000USD | -170,473,000USD |
| Cash | 4,576,000USD | 8,740,000USD | 12,620,000USD | 13,159,000USD | 63,458,000USD | 16,455,000USD | 5,154,000USD | 114,597,000USD |
| Cash And Short Term Investments | 56,750,000USD | 51,964,000USD | 27,149,000USD | 42,303,000USD | 69,451,000USD | 44,259,000USD | 77,982,000USD | 114,597,000USD |
| Total Current Assets | 58,214,000USD | 54,407,000USD | 27,956,000USD | 43,664,000USD | 71,312,000USD | 45,336,000USD | 79,344,000USD | 114,597,000USD |
| Total Current Liabilities | 9,380,000USD | 35,402,000USD | 6,869,000USD | 10,752,000USD | 9,692,000USD | 12,149,000USD | 10,225,000USD | 7,896,000USD |
| Net Debt | -3,639,000USD | -7,618,000USD | -11,246,000USD | -10,558,000USD | -59,811,000USD | -14,145,000USD | -1,966,000USD | -114,597,000USD |
| Short Term Debt | 403,000USD | 185,000USD | 1,374,000USD | 1,228,000USD | 1,046,000USD | 1,078,000USD | 878,000USD | — |
| Short Long Term Debt Total | 937,000USD | 1,122,000USD | 1,374,000USD | 2,601,000USD | 3,647,000USD | 2,310,000USD | 3,188,000USD | — |
| Long Term Investments | 10,991,000USD | 12,540,000USD | 16,123,000USD | 21,877,000USD | 34,266,000USD | 37,225,000USD | — | — |
| Short Term Investments | 52,174,000USD | 43,224,000USD | 14,529,000USD | 29,144,000USD | 5,993,000USD | 27,804,000USD | 72,828,000USD | 75,401,000USD |
| Net Receivables | 374,000USD | 216,000USD | 63,000USD | 633,000USD | 539,000USD | 86,000USD | 329,000USD | 337,000USD |
| Accounts Payable | 2,491,000USD | 2,582,000USD | 1,525,000USD | 1,976,000USD | 1,565,000USD | 3,467,000USD | 2,448,000USD | 1,998,000USD |
| Property Plant Equipment Net | 1,059,000USD | 1,328,000USD | 1,385,000USD | 2,570,000USD | 3,641,000USD | 2,554,000USD | 3,789,000USD | 2,180,000USD |
| Property Plant Equipment Gross | 3,708,000USD | 5,954,000USD | 6,082,000USD | 2,217,000USD | 3,190,000USD | 2,554,000USD | 3,789,000USD | 2,180,000USD |
| Accumulated Other Comprehensive Income | -896,000USD | -1,288,000USD | -967,000USD | -563,000USD | 1,869,000USD | 4,000USD | 29,000USD | -34,000USD |
| Common Stock Shares Outstanding | 79,742,685shares | 60,985,165shares | 48,025,274shares | 46,553,511shares | 41,854,110shares | 29,479,000shares | 29,350,000shares | 27,510,000shares |
| Non Current Assets Total | 12,905,000USD | 14,500,000USD | 17,597,000USD | 24,576,000USD | 38,143,000USD | 40,193,000USD | 4,302,000USD | 3,635,000USD |
| Non Current Liabilities Total | 533,999USD | 937,000USD | 0USD | 1,373,000USD | 2,601,000USD | 1,232,000USD | 2,310,000USD | 869,000USD |
| Non Currrent Assets Other | 855,000USD | 632,000USD | 89,000USD | 129,000USD | 236,000USD | 414,000USD | 513,000USD | 1,455,000USD |
| Net Working Capital | 48,834,000USD | 19,005,000USD | 21,087,000USD | 32,912,000USD | 61,620,000USD | 33,187,000USD | 69,119,000USD | 108,562,000USD |
| Unclassified Equity | 474,380,000USD | 430,852,000USD | 374,358,000USD | 364,356,000USD | 361,664,000USD | 295,278,000USD | 288,221,000USD | 280,837,000USD |
| Other Assets | — | — | 1USD | 129,000USD | 236,000USD | 414,000USD | 513,000USD | 463,000USD |
| Inventory | — | — | — | -735,000USD | -667,000USD | -492,000USD | -815,000USD | -602,000USD |
| Net Tangible Assets | — | — | — | 56,115,000USD | 97,162,000USD | 72,148,000USD | 71,111,000USD | 110,336,000USD |
| Unclassified Non Current Liabilities | — | — | — | 1,373,000USD | 2,601,000USD | 1,232,000USD | 2,310,000USD | — |
| Current Deferred Revenue | — | — | — | — | 6,960,000USD | — | — | — |
| Unclassified Current Liabilities | — | — | — | — | -6,960,000USD | — | — | — |
| Other Liab | — | — | — | — | — | — | — | 869,000USD |
| Unclassified Current Assets | — | — | — | — | — | — | — | -76,393,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -13,692,000USD | -12,321,000USD | -10,157,000USD | -7,998,000USD | 15,193,000USD | -12,113,000USD | -40,217,000USD | -4,262,000USD |
| Depreciation | 29,000USD | 26,000USD | 28,000USD | 29,000USD | 22,000USD | 20,000USD | 21,000USD | 21,000USD |
| Stock Based Compensation | 2,650,000USD | 1,574,000USD | 1,249,000USD | 1,256,000USD | 1,251,000USD | 845,000USD | 701,000USD | 768,000USD |
| Other Non Cash Items | 582,000USD | 446,000USD | -136,000USD | -1,957,000USD | -24,881,000USD | 4,242,000USD | 32,848,000USD | -1,463,000USD |
| Change To Account Receivables | -6,000USD | -5,000USD | 54,000USD | -7,000USD | -4,000USD | -5,000USD | -35,000USD | -9,000USD |
| Change In Working Capital | 57,000USD | 1,084,000USD | -550,000USD | 2,893,000USD | 152,000USD | -1,459,000USD | 326,000USD | -545,000USD |
| Total Cash From Operating Activities | -10,374,000USD | -9,191,000USD | -9,566,000USD | -5,777,000USD | -8,263,000USD | -8,465,000USD | -6,321,000USD | -5,481,000USD |
| Capital Expenditures | -91,000USD | -25,000USD | 0USD | -113,000USD | -36,000USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -10,465,000USD | -9,216,000USD | -9,566,000USD | -5,890,000USD | -8,299,000USD | -8,465,000USD | -6,321,000USD | -5,481,000USD |
| Investments | -144,755,000USD | 10,905,000USD | -2,618,000USD | -20,301,000USD | 4,243,000USD | -6,083,000USD | -3,890,000USD | -17,504,000USD |
| Total Cashflows From Investing Activities | -144,846,000USD | 10,880,000USD | -2,618,000USD | -20,301,000USD | 4,243,000USD | -6,083,000USD | -3,890,000USD | -17,504,000USD |
| Total Cash From Financing Activities | 190,746,000USD | 20,000USD | 360,000USD | 35,770,000USD | 279,000USD | 18,608,000USD | 50,000USD | 30,370,000USD |
| Issuance Of Capital Stock | 189,407,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Change In Cash | 35,526,000USD | 1,709,000USD | -11,824,000USD | 9,692,000USD | -3,741,000USD | 4,060,000USD | -10,161,000USD | 7,385,000USD |
| Begin Period Cash Flow | 4,576,000USD | 2,867,000USD | 14,691,000USD | 4,999,000USD | 8,740,000USD | 4,680,000USD | 14,841,000USD | 7,456,000USD |
| End Period Cash Flow | 40,102,000USD | 4,576,000USD | 2,867,000USD | 14,691,000USD | 4,999,000USD | 8,740,000USD | 4,680,000USD | 14,841,000USD |
| Other Cashflows From Financing Activities | 190,746,000USD | 20,000USD | 360,000USD | — | 279,000USD | 18,608,000USD | 50,000USD | 30,370,000USD |
| Unclassified Financing Cash Flow | -189,407,000USD | — | — | 35,770,000USD | — | — | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 5,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -15,283,000USD | -62,293,000USD | -27,029,000USD | -41,307,000USD | -43,241,000USD | -46,939,000USD | -55,663,000USD | -36,375,000USD |
| Depreciation | 105,000USD | 85,000USD | 151,000USD | 367,000USD | 460,000USD | 847,000USD | 842,000USD | 594,000USD |
| Stock Based Compensation | 5,330,000USD | 3,003,000USD | 2,147,000USD | 2,692,000USD | 4,232,000USD | 7,135,000USD | 6,229,000USD | 3,828,000USD |
| Other Non Cash Items | -26,528,000USD | 35,428,000USD | 4,390,000USD | 9,813,000USD | 5,070,000USD | -608,000USD | -195,000USD | 4,476,000USD |
| Change To Account Receivables | 38,000USD | -49,000USD | 562,000USD | -81,000USD | -507,000USD | -507,000USD | 0USD | 0USD |
| Change In Working Capital | 3,579,000USD | -1,647,000USD | -3,594,000USD | 1,412,000USD | -3,236,000USD | -1,423,000USD | 2,575,000USD | 3,448,000USD |
| Total Cash From Operating Activities | -32,797,000USD | -25,424,000USD | -23,935,000USD | -27,023,000USD | -36,715,000USD | -40,988,000USD | -46,212,000USD | -27,857,000USD |
| Capital Expenditures | -174,000USD | 0USD | -34,000USD | -269,000USD | -5,000USD | -355,000USD | -266,000USD | -2,199,000USD |
| Free Cash Flow | -32,971,000USD | -25,424,000USD | -23,969,000USD | -27,292,000USD | -36,720,000USD | -41,343,000USD | -46,478,000USD | -30,056,000USD |
| Investments | -7,622,000USD | -27,484,000USD | 13,977,000USD | -23,276,000USD | 21,565,000USD | -29,837,000USD | 84,826,000USD | -42,556,000USD |
| Total Cashflows From Investing Activities | -7,796,000USD | -27,484,000USD | 15,541,000USD | -23,276,000USD | 21,560,000USD | -30,192,000USD | 84,826,000USD | -42,556,000USD |
| Total Cash From Financing Activities | 36,429,000USD | 49,028,000USD | 7,855,000USD | 18,000USD | 62,158,000USD | 65,270,000USD | 1,442,000USD | 71,358,000USD |
| Issuance Of Capital Stock | 0USD | 16,405,000USD | 7,843,000USD | 7,516,000USD | 60,943,000USD | 64,877,000USD | — | — |
| Change In Cash | -4,164,000USD | -3,880,000USD | -539,000USD | -50,299,000USD | 47,003,000USD | -5,910,000USD | 40,056,000USD | 945,000USD |
| Begin Period Cash Flow | 8,740,000USD | 12,620,000USD | 13,159,000USD | 63,458,000USD | 16,455,000USD | 45,106,000USD | 5,050,000USD | 4,105,000USD |
| End Period Cash Flow | 4,576,000USD | 8,740,000USD | 12,620,000USD | 13,159,000USD | 63,458,000USD | 39,196,000USD | 45,106,000USD | 5,050,000USD |
| Other Cashflows From Financing Activities | 36,429,000USD | 32,623,000USD | 12,000USD | -23,276,000USD | 1,215,000USD | 393,000USD | 731,000USD | 4,000USD |
| Other Cashflows From Investing Activities | — | 5,000USD | — | -23,007USD | 21,565USD | -29,837,000USD | 85,092,000USD | -40,357,000USD |
| Unclassified Investing Cash Flow | — | — | 1,598,000USD | — | — | 29,837,000USD | -84,826,000USD | 42,556,000USD |
| Change To Liabilities | — | — | — | 411,000USD | -1,902,000USD | -2,016,000USD | 1,554,000USD | 518,000USD |
| Unclassified Financing Cash Flow | — | — | — | 15,778,000USD | — | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | 65,270,000USD | 1,442,000USD | 71,358,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | -5,910,000USD | 40,056,000USD | 945,000USD |
| Change To Inventory | — | — | — | — | — | — | 0USD | 0USD |
| Dividends Paid | — | — | — | — | — | — | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | — | -3,828,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.